We are live on
!
Find out more
VanEck Associates Portfolio holdings
AUM
$133B
1-Year Est. Return
72.99%
This Fund
S&P 500
This Quarter
Est. Return
+12.72%
1 Year Est. Return
+72.99%
3 Year Est. Return
+157.94%
5 Year Est. Return
+206.35%
10 Year Est. Return
+770.56%
AUM
$31.4B
AUM Growth
+$2.72B
(+9.5%)
Cap. Flow
+$31.8M
Cap. Flow
% of AUM
0.1%
Top 10 Holdings %
Top 10 Hldgs %
39.84%
Holding
1,057
New
52
Increased
555
Reduced
391
Closed
42
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
SSR Mining
SSRM
|
+$217M |
| 2 |
Kinross Gold
KGC
|
+$120M |
| 3 |
B2Gold
BTG
|
+$94.6M |
| 4 |
Gold Fields
GFI
|
+$80.9M |
| 5 |
Applied Materials
AMAT
|
+$76.4M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Sibanye-Stillwater
SBSW
|
+$275M |
| 2 |
Newmont
NEM
|
+$224M |
| 3 |
B
Barrick Mining
B
|
+$221M |
| 4 |
Franco-Nevada
FNV
|
+$129M |
| 5 |
Wheaton Precious Metals
WPM
|
+$91.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Materials | 59.5% |
| 2 | Technology | 13.57% |
| 3 | Healthcare | 5.48% |
| 4 | Financials | 3.32% |
| 5 | Consumer Discretionary | 2.86% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
226
Cencora
COR
$61.8B
| $13.1M | 0.04% |
134,757
+7,743
| +6% | +$770K |
|
227
BioMarin Pharmaceuticals
BMRN
$11.6B
| $12.9M | 0.04% |
169,748
-33,697
| -17% | -$3.41M |
|
|
CNH
228
CNH Industrial
CNH
$13.6B
| $12.8M | 0.04% |
1,887,989
+75,319
| +4% | +$499K |
|
229
Nuveen AMT-Free Municipal Credit Income Fund
NVG
$2.67B
| $12.8M | 0.04% |
818,418
+29,019
| +4% | +$455K |
|
230
Prologis
PLD
$132B
| $12.8M | 0.04% |
127,168
-83,426
| -40% | -$8.36M |
|
231
Nuveen Quality Municipal Income Fund
NAD
$2.75B
| $12.8M | 0.04% |
879,189
+14,555
| +2% | +$211K |
|
232
Nuveen AMT-Free Quality Municipal Income Fund
NEA
$3.39B
| $12.7M | 0.04% |
887,814
+8,801
| +1% | +$126K |
|
233
Alnylam Pharmaceuticals
ALNY
$30.4B
| $12.6M | 0.04% |
86,439
-24,559
| -22% | -$3.49M |
|
234
Starwood Property Trust
STWD
$5.97B
| $12.5M | 0.04% |
826,904
-108,123
| -12% | -$1.65M |
|
|
INVX
235
Innovex International
INVX
$2.13B
| $12.3M | 0.04% |
498,560
-106,084
| -18% | -$3.38M |
|
|
NVO
236
Novo Nordisk
NVO
$199B
| $12.3M | 0.04% |
354,486
+35,464
| +11% | +$1.18M |
|
|
LAC
237
DELISTED
Lithium Americas Corp. Common Shares
LAC
| $12.3M | 0.04% |
+1,078,725
| New | +$7.69M |
|
238
AstraZeneca
AZN
$251B
| $12.1M | 0.04% |
110,116
+154
| +0.1% | +$17.1K |
|
239
Lowe's Companies
LOW
$123B
| $12M | 0.04% |
72,436
-7,156
| -9% | -$1.1M |
|
240
Goldgroup Mining Inc.
GORO
$165M
| $11.9M | 0.04% |
3,495,169
+231,589
| +7% | +$943K |
|
|
FSKR
241
DELISTED
FS KKR Capital Corp. II
FSKR
| $11.8M | 0.04% |
+800,004
| New | +$11.4M |
|
|
GSV
242
DELISTED
Gold Standard Ventures Corp.
GSV
| $11.7M | 0.04% |
14,996,396
+1,950,554
| +15% | +$1.66M |
|
243
Novartis
NVS
$293B
| $11.6M | 0.04% |
133,906
-148
| -0.1% | -$12.8K |
|
|
OCFT
244
DELISTED
OneConnect Financial Technology
OCFT
| $11.5M | 0.04% |
54,214
+54,207
| +774,386% | +$11.8M |
|
245
Sanofi
SNY
$103B
| $11.5M | 0.04% |
228,805
-80
| -0% | -$4.12K |
|
|
DTP
246
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
| $11.1M | 0.04% |
245,560
-5,242
| -2% | -$236K |
|
247
Hercules Capital
HTGC
$3.11B
| $11.1M | 0.04% |
955,181
-8,113
| -0.8% | -$90.2K |
|
248
Golub Capital BDC
GBDC
$3.33B
| $11M | 0.04% |
833,477
-35,437
| -4% | -$443K |
|
|
CTLT
249
DELISTED
CATALENT, INC.
CTLT
| $10.9M | 0.03% |
127,437
+10,387
| +9% | +$878K |
|
250
Toro Company
TTC
$9.45B
| $10.9M | 0.03% |
129,841
-4,535
| -3% | -$339K |
|
Similar funds
VanEck Associates's Q3 2020 Portfolio in Review
As of Q3 2020, VanEck Associates held 1,057 positions worth $31.4B, up 9.5% from $28.7B the previous quarter. Its ten largest holdings account for 40% of the portfolio.
VanEck Associates's Q3 2020 filing shows 52 new, 555 increased, 391 reduced and 42 closed positions. Its largest new stake was Corvus Gold Inc. Common Shares: 8,706,556 shares worth $25.6M. The largest sale was Sibanye-Stillwater, an estimated $275M.
By sector, the portfolio is most concentrated in Materials at 59% of assets, up from 59% a quarter earlier, followed by Technology and Healthcare.
- VanEck Associates's largest Q3 2020 buy was Corvus Gold Inc. Common Shares: 8,706,556 shares worth $25.6M.
- VanEck Associates added most to SSR Mining in Q3 2020, an estimated $217M increase.
- VanEck Associates's biggest Q3 2020 reduction was Sibanye-Stillwater, cutting an estimated $275M.
- VanEck Associates fully exited State Street in Q3 2020, selling an estimated $49.6M.
- VanEck Associates's ten largest holdings make up 40% of its $31.4B portfolio in Q3 2020.
- VanEck Associates opened 52 new positions and closed 42 in Q3 2020.
- VanEck Associates's portfolio value rose 9.5% quarter-over-quarter to $31.4B.
Based on VanEck Associates's 13F filing for Q3 2020, filed 12 Nov 2020.